Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.58|
|52 Week High||AU$0.28|
|52 Week Low||AU$0.70|
|1 Month Change||12.50%|
|3 Month Change||31.46%|
|1 Year Change||88.71%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||225.00%|
Recent News & Updates
|BMT||AU Healthcare Services||AU Market|
Return vs Industry: BMT exceeded the Australian Healthcare Services industry which returned 42.9% over the past year.
Return vs Market: BMT exceeded the Australian Market which returned 21.3% over the past year.
Stable Share Price: BMT is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: BMT's weekly volatility (11%) has been stable over the past year.
About the Company
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, a solution that audit data in real-time in pathology, including data entry, billing, and specimen reception; and PICQ, a coding quality tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference for clinical coding patient records.
Beamtree Holdings Fundamentals Summary
|BMT fundamental statistics|
Is BMT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BMT income statement (TTM)|
|Cost of Revenue||AU$5.62m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.0016|
|Net Profit Margin||-4.57%|
How did BMT perform over the long term?See historical performance and comparison
Is Beamtree Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate BMT's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate BMT's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: BMT is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.
PE vs Market: BMT is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BMT's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: BMT is good value based on its PB Ratio (3.4x) compared to the AU Healthcare Services industry average (4.2x).
How is Beamtree Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BMT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Earnings vs Market: BMT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BMT's is expected to become profitable in the next 3 years.
Revenue vs Market: BMT's revenue (46% per year) is forecast to grow faster than the Australian market (5.3% per year).
High Growth Revenue: BMT's revenue (46% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BMT's Return on Equity is forecast to be low in 3 years time (9%).
How has Beamtree Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BMT is currently unprofitable.
Growing Profit Margin: BMT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: BMT is unprofitable, and losses have increased over the past 5 years at a rate of 76.7% per year.
Accelerating Growth: Unable to compare BMT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BMT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (37.7%).
Return on Equity
High ROE: BMT has a negative Return on Equity (-0.91%), as it is currently unprofitable.
How is Beamtree Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: BMT's short term assets (A$17.4M) exceed its short term liabilities (A$3.8M).
Long Term Liabilities: BMT's short term assets (A$17.4M) exceed its long term liabilities (A$1.2M).
Debt to Equity History and Analysis
Debt Level: BMT is debt free.
Reducing Debt: BMT has not had any debt for past 5 years.
Debt Coverage: BMT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: BMT has no debt, therefore coverage of interest payments is not a concern.
What is Beamtree Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate BMT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BMT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BMT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BMT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of BMT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Tim Kelsey has been Commercial Director at Telstra Health since July 1, 2016. Mr. Kelsey serves as the Chief Executive Officer at Beamtree Holdings Limited (formerly known as PKS Holdings Limited) sinc...
CEO Compensation Analysis
Compensation vs Market: Tim's total compensation ($USD551.33K) is above average for companies of similar size in the Australian market ($USD302.38K).
Compensation vs Earnings: Insufficient data to compare Tim's compensation with company performance.
Experienced Management: BMT's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Experienced Board: BMT's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: BMT insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.4%.
Beamtree Holdings Limited's employee growth, exchange listings and data sources
- Name: Beamtree Holdings Limited
- Ticker: BMT
- Exchange: ASX
- Founded: 1996
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: AU$142.878m
- Shares outstanding: 244.24m
- Website: https://beamtree.com.au
Number of Employees
- Beamtree Holdings Limited
- 16 Eveleigh Street
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/25 16:59|
|End of Day Share Price||2021/10/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.